RxDoctor Payments Data

David Jackson, NP

Family · Valdosta, GANPI 1215079983

Payments from drug & device makers

$1,923in general payments, 2019–2025

Across 111 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$190
  • Pfizer$189
  • AbbVie$157
  • AstraZeneca$120
  • Paratek Pharmaceuticals, Inc.$104
  • Astellas Pharma US Inc$100
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$1,82395%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,923 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$40,010
Medicare patients
159
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide44$51,986
LinzessLinaclotide44$27,027
OzempicSemaglutide27$26,294
TrulicityDulaglutide24$24,158
EliquisApixaban21$18,328
JardianceEmpagliflozin11$14,856
TradjentaLinagliptin19$9,397
Spiriva RespimatTiotropium Bromide16$9,384
FarxigaDapagliflozin Propanediol15$8,717
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,554
BrilintaTicagrelor11$4,695
Testosterone18$3,531
PremarinEstrogens, Conjugated14$3,215
Albuterol Sulfate HfaAlbuterol Sulfate109$2,555
Dexlansoprazole DrDexlansoprazole14$2,096

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$46$76,14468 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$18$33,63746 claims
AbbVieLinzess$157$27,02744 claims
Novo NordiskOzempic$190$26,29427 claims
PfizerEliquis, Premarin$189$21,54335 claims
AstraZenecaFarxiga, Brilinta$120$13,41226 claims
GSKTrelegy Ellipta$15$7,55412 claims
Scilex Pharmaceuticals Inc.Colchicine$43$73325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →